USA - New York Stock Exchange - NYSE:APH - US0320951017 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to APH. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-14 | UBS | Maintains | Buy -> Buy |
| 2026-01-12 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2026-01-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-19 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-13 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-23 | UBS | Maintains | Buy -> Buy |
| 2025-10-23 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-23 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-23 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-23 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-15 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-10-10 | Baird | Maintains | Outperform -> Outperform |
| 2025-10-08 | Barclays | Initiate | Equal-Weight |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-06 | UBS | Maintains | Buy -> Buy |
| 2025-09-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-09-24 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-19 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-05 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-07-24 | UBS | Maintains | Buy -> Buy |
| 2025-07-24 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-24 | Baird | Maintains | Outperform -> Outperform |
| 2025-07-24 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-18 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-07-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-14 | UBS | Maintains | Buy -> Buy |
| 2025-07-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-06-10 | Goldman Sachs | Maintains | Buy -> Buy |
25 analysts have analysed APH and the average price target is 153.38 USD. This implies a price decrease of -0.65% is expected in the next year compared to the current price of 154.39.
The consensus rating for AMPHENOL CORP-CL A (APH) is 77.6 / 100 . This indicates that analysts generally have a positive outlook on the stock.